About 20 employees are affected, about 50% of its workforce, according to Bolt Biotherapeutics, Inc.'s latest layoff filing, on October 2, 2025. As of November 8, 2026, Bolt Biotherapeutics, Inc. has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, October 2, 2025).
Who owns Bolt Biotherapeutics, Inc.?
12 companies announced layoffs this week.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| Artiva Biotherapeutics, Inc. | announced layoffs | |
| Eos Energy Enterprises, Inc. | announced layoffs | |
| SOUNDHOUND AI, INC. | announced layoffs | |
| Portillo's Inc. | announced layoffs | |
| Acumen Pharmaceuticals, Inc. | announced layoffs of about 52 employees |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Bolt Biotherapeutics, Inc.
Free to see. No signup.
Bolt Biotherapeutics, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05, 1 of 1 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Bolt Biotherapeutics have layoffs in 2025? What its filings say
Bolt Biotherapeutics, Inc. (CIK 1641281) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2025-10-02
Employees affected
The restructuring plan includes a reduction of the Company's current workforce by approximately 20 employees, or approximately 50% of the Company's workforce.
Expected charges
The Company estimates that it will incur aggregate pre-tax charges between approximately $1.5 million to $2.0 million in connection with the reduction-in-force, primarily consisting of severance payments, employee benefits, and related costs.
Timing
The Company expects that the reduction-in-force will be complete by the end of 2025 and that the associated charges will be recorded in the fourth quarter of 2025.
Also on the record for Bolt Biotherapeutics, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 6, 2026 | Stake report, Schedule 13G, by Coastlands Capital LP | 17.5% of the class | 5%+ stakes | Source |
| October 23, 2026 | Leadership change: Sheila Gujrathi appointed, Director, and 1 more | — | Leadership changes | Source |
| August 13, 2026 | Stake report, Schedule 13G, by Renaissance Technologies LLC | 5.13% of the class | 5%+ stakes | Source |
| February 26, 2026 | Stake report, Schedule 13D/A, by Pivotal bioVenture Partners Fund I, L.P. | 4.6% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13D/A, by Pivotal bioVenture Partners Fund I, L.P. | 6.7% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Vivo Panda Fund, L.P. | 3.8% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by TANG CAPITAL MANAGEMENT, LLC | 3.5% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by TANG CAPITAL MANAGEMENT, LLC | 3.5% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by TANG CAPITAL MANAGEMENT, LLC | 8.7% of the class | 5%+ stakes | Source |
Keep reading
More on Bolt Biotherapeutics, Inc. and the records around it.
Bolt Biotherapeutics, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Leadership changes Oct 2026
- Who owns it
Companies that share a holder
- Nan Fung Group Holdings Limited also filed stake reports on 2 other companies: Evommune, Inc. (Feb 2026), Oculis Holding AG (Nov 2025)
- Coastlands Capital LP also filed stake reports on 16 other companies: Sutro Biopharma, Inc. (Nov 2026), Kalaris Therapeutics, Inc. (Oct 2026), Frazier Life Sciences Acquisition Corp. II (Oct 2026)
- TANG CAPITAL MANAGEMENT, LLC also filed stake reports on 33 other companies: EyePoint, Inc. (Oct 2026), Skye Bioscience, Inc. (Oct 2026), Nano Dimension Ltd. (Aug 2026)
Watch Bolt Biotherapeutics, Inc.
Get an email when Bolt Biotherapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Bolt Biotherapeutics, Inc.?
Want the whole picture on Bolt Biotherapeutics, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Bolt Biotherapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Bolt Biotherapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Tools for this story
Each opens in a new tab, filled in for Bolt Biotherapeutics, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Cite this page
https://mentionfox.com/layoffs/bolt-biotherapeutics